Comparison of Psoriasis Area and Severity Index (PASI) Scores in Patients Treated with Oral Methotrexate and A Combination of Oral Methotrexate and Narrow Band-Ultraviolet B (NB-UVB) Phototherapy
Downloads
Background: Psoriasis Vulgaris is an autoimmune disease characterized by chronic skin inflammation and epidermal hyperplasia. Psoriasis Area Severity Index (PASI) score is one of the assessments to measure the psoriasis severity. Oral methotrexate is one of the effective therapies for psoriasis patients. Narrow Band-Ultraviolet B (NB-UVB) phototherapy is an adjunctive psoriasis therapy given concurrently with oral methotrexate. Purpose: Determine the difference in Psoriasis Area Severity Index (PASI) scores between Psoriasis Vulgaris patients treated with oral methotrexate and a combination of oral methotrexate and NB-UVB phototherapy. Methods: This observational analytic study was conducted at the Dermatology and Venereology Clinic, Dr. Moewardi General Hospital Surakarta. The patients received oral methotrexate and a combination of oral methotrexate and and Narrow Band-Ultraviolet B (NB-UVB) phototherapy. A retrospective study of medical records was conducted to determine the patient's PASI score before the therapies and 3 months after. All data were analyzed with the Shapiro Wilk normality test and the independent T-test. A p-value was <0.05, and it was considered significant. Result: The mean of decreased PASI scores in the oral methotrexate group was (6.00 +2.47) and (6.08 +2.17) in the combination therapy group. Based on the statistical test results from the 24 subjects, it was found that the PASI score decreased (p=0.931). Conclusion: There was no significant difference in the decrease in PASI between the oral methotrexate group and the combination therapy group. The mean reduction of PASI scores was more significant in the combination therapy than in the methotrexate group
Springate DA, Parisi R, Kontopantelis E, Reeves D, Griffiths CEM, Ashcroft DM. Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol. 2017;176(3):650–8.
Lí¸nnberg AS, Skov L, Skytthe A, Kyvik KO, Pedersen OB, Thomsen SF. Association of Psoriasis With the Risk for Type 2 Diabetes Mellitus and Obesity. JAMA Dermatology. 2016;152(7):761.
Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;m1590.
Damayanti KDP. Profil Psoriasis Vulgaris di RSUD Dr. Soetomo Surabaya : Studi Retropektif (Psoriasis Vulgaris : A Retrospective Study). Berk Ilmu Kesehat Kulit dan Kelamin – Period Dermatology Venereol. 2018;30(3):248–54.
Gudjonsson J, Elder J. Psoriasis. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick's Dermatology Vol1. 9th ed. New York: McGraw-Hill; 2018. p. 457-97.
Soliman A, Nofal E, Nofal A, El desouky F, Asal M. Combination therapy of methotrexate plus NBUVB phototherapy is more effective than methotrexate monotherapy in the treatment of chronic plaque psoriasis. J Dermatolog Treat. 2015;26(6):528–34.
Damevska K, França K, Lotti T, Nikolovska S, Pollozhani N. Complementary and integrative therapies for psoriasis: Looking forward. Dermatol Ther. 2018;31(5):e12627.
Souza CS, de Castro CCS, Carneiro FRO, Pinto JMN, Fabricio LHZ, Azulay-Abulafia L, et al. Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence. J Dermatol. 2019;46(1):3–10.
Oliveira M de FSP de, Rocha B de O, Duarte GV. Psoriasis: classical and emerging comorbidities. An Bras Dermatol. 2015;90(1):9–20.
Georgescu S-R, Tampa M, Caruntu C, Sarbu M-I, Mitran C-I, Mitran M-I, et al. Advances in Understanding the Immunological Pathways in Psoriasis. Int J Mol Sci. 2019;20(3):739.
Sigit Prakoeswa CR, Hidayati AN, Hendaria MP, Listiawan MY, Utomo B, Damayanti D, et al. The Profile of Psoriasis Vulgaris Patients: A Descriptive Study. Berkala Ilmu Kesehatan Kulit dan Kelamin. 2021;33(3):173.
Mitran M, Mitran C, Sí¢rbu M, Benea V, Tampa M, Georgescu S. Therapeutic challenges in a case of psoriasis with nail onset. J Mind Med Sci. 2017;4(2):186–92.
Van de Kerkhof P, Nestle F. Psoriasis. In: Bologna JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. Philadelphia: Elsevier; 2012. p. 135–56.
Hägg D, Sundström A, Eriksson M, Schmitt-Egenolf M. Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients. Am J Clin Dermatol. 2017;18(4):583–90.
Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia (PERDOSKI). Psoriasis. In: Widaty S, Soebono H, Nilasari H, Listiawan MY, Siswati AS, Triwahyudi D, et al., editors. Panduan Praktik Klinis bagi Dokter Spesialis Kulit dan Kelamin di Indonesia. Jakarta: PERDOSKI; 2017. 233–237 p.
Suwarsa O, Khairani FA, Isneny SU, Avriyanti E, Dharmadji HP, Pangastuti M, et al. The Effect of Systemic Methotrexate and Cyclosporine Combination Therapy inPsoriasis Vulgaris Patients in Bandung, Indonesia. Berkala Ilmu Kesehat Kulit dan Kelamin. 2021;33(3):200.
Budianti WK, Anindya S, Debinta AA, Novianto E, Fitri EM, Halim E. Kesesuaian Tata Laksana Psoriasis dengan Panduan Praktik Klinis (PPK) Di RSUPN Dr. Cipto Mangunkusumo. Media Derm Venereol Indones. 2019;46(4).
Haider S, Wahid Z, Saher NU, Riaz F. Efficacy of Methotrexate in patients with plaque type psoriasis. Pakistan J Med Sci. 1969;30(5).
Shen S, O'Brien T, Yap LM, Prince HM, McCormack CJ. The use of methotrexate in dermatology: a review. Australas J Dermatol. 2012;53(1):1–18.
Singh RK, Lee KM, Jose M V., Nakamura M, Ucmak D, Farahnik B, et al. The Patient's Guide to Psoriasis Treatment. Part 1: UVB Phototherapy. Dermatol Ther (Heidelb). 2016;6(3):307–13.
El-Hamd MA, El Saied ARA, Ahmed SH, Ibrahim HM, Hegazy EM. Effect of narrow-band ultraviolet B phototherapy, methotrexate, and combined narrow-band ultraviolet B phototherapy with methotrexate on serum cathelicidin and vitamin D in patients with psoriasis vulgaris. J Dermatolog Treat. 2020;1–7.
Khadka DK, Agrawal S, Dhali TK. Methotrexate plus narrow band ultraviolet B (NBUVB) versus methotrexate alone in the treatment of moderate to severe plaque psoriasis: A randomized clinical trial. Nepal J Dermatology, Venereol Leprol. 2016;13(1):12–23.
Copyright (c) 2022 Berkala Ilmu Kesehatan Kulit dan Kelamin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
